EE+ POEM Archive
Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO) is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Semuloparin Reduces VTE in Cancer Patients but at High Cost (SAVE-ONCO)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/427535/all/Semuloparin_reduces_VTE_in_cancer_patients_but_at_high_cost__SAVE_ONCO_.
Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427535/all/Semuloparin_reduces_VTE_in_cancer_patients_but_at_high_cost__SAVE_ONCO_. Accessed December 5, 2022.
Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427535/all/Semuloparin_reduces_VTE_in_cancer_patients_but_at_high_cost__SAVE_ONCO_
Semuloparin Reduces VTE in Cancer Patients but at High Cost (SAVE-ONCO) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2022 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427535/all/Semuloparin_reduces_VTE_in_cancer_patients_but_at_high_cost__SAVE_ONCO_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
ID - 427535
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427535/all/Semuloparin_reduces_VTE_in_cancer_patients_but_at_high_cost__SAVE_ONCO_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
